Nexsen secures first hospital partner in Asia

Nexsen enters a strategic collaboration with GHK Hospital Limited—part of IHH Healthcare—to validate and advance its rapid diagnostic platform across Asia. This positions Nexsen for real-world adoption, platform expansion, and future growth.

<ul><li>Signed binding term sheet with GHK Hospital Limited, owned by IHH Healthcare, to clinically validate and commercialise Nexsen’s rapid point-of-care diagnostic platform.</li><li>Collaboration provides access to patient populations and real-world hospital workflows for clinical validation, real-world data generation, and reimbursement assessment.</li><li>Strengthens Asia-Pacific strategy with a third foundational partner, leveraging non-dilutive funding and institutional collaborations in Hong Kong and Malaysia.</li><li>Potential for platform expansion, joint R&D, grant applications, and new product development beyond current pipeline.</li><li>Initial focus on clinical validation for Group B Streptococcus and Kidney Function diagnostics, with plans to formalise collaboration agreements within six months.</li></ul>

ASX:

$

00%

Nexsen secures first hospital partner in Asia